Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa.

Translated title of the contribution: Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa.

D.A.M.C. van de Vijver, R.A.C. Roos, P.A.F. Jansen, A.J. Porsius, A. de Boer

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionStart of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa.
Original languageUndefined/Unknown
Pages (from-to)168-170
Number of pages3
JournalBritish Journal of Clinical Pharmacology
Volume54
Publication statusPublished - 2002

Keywords

  • Econometric and Statistical Methods: General
  • Epidemiology
  • Farmacie(FARM)
  • Geneeskunde(GENK)
  • Bescherming en bevordering van de menselijke gezondheid
  • Biomedische technologie en medicijnen
  • Ziekenhuisstructuur en organisatie van de gezondheidszorg
  • Public Health
  • Internal medicine

Cite this